{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-21-006007","form_type":"8-K","ticker":"SLSN","cik":"0000883107","company_name":"SOLESENCE, INC.","filed_at":"2021-08-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.062576+00:00","generated_at":"2026-06-29T09:43:59.129541+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nanophase reports record Q2 revenue of $7.1M; Solésence beauty science revenue up 210% YoY to $8.8M in H1","bullets":["Record Q2 revenue $7.1M vs $4.3M in Q2 2020 (YoY +65%).","H1 2021 revenue $14.2M (+69% YoY); net income $1.4M compared to $0.4M.","Solésence beauty science H1 revenue $8.8M, up 210% from $2.8M, exceeding full-year 2020.","PPP loan $1.0M forgiven by SBA; non-cash interest $0.9M from conversion of related party loan.","Cash at quarter end $1.1M; purchase orders >$20M, half expected to ship in H2 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-21-006007","json":"https://secwatch.observer/filing/0001171843-21-006007.json","markdown":"https://secwatch.observer/filing/0001171843-21-006007.md","text":"https://secwatch.observer/filing/0001171843-21-006007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883107/000117184321006007/0001171843-21-006007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883107/000117184321006007/f8k_081421.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T09:43:59.129541+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}